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Abstract. The aim of this study was to identify the most common bacterial cause of urinary tract infections and 
the patterns of antimicrobial resistance. The study was conducted at Dr. Zainoel Abidin Teaching Hospital, Banda 
Aceh, Indonesia with descriptive retrospective study approach.  The data was taken from medical records. One 
hundred and nineteen bacterials was identified, encountered gram-negative bacteria namely Escherichia coli 
(31.7%), Klebsiella pneumoniae (27.7%), Acinetobacter (12.6%), Pseudomonas aeruginosa (10.1%), 
Enterobacter (5.1%) and Proteus mirabilis (0.8%). Meanwhile encountered gram-positive bacteria were Beta-
hemolytic Streptococci (9.2%) and Staphylococcus aureus (3.4%). Observations on the sensitivity profile 
suggested that the pathogenic gram-negative bacteria had a high resistance against ampicilin, ciprofloxacin, 
cefuroxime and cefotaxime, while meropenem, chloramphenicol, gentamicin and tobramycin have a high 
sensitivity level. Descriptive analysis also found pathogenic gram-positive bacteria showed high resistance to 
ceftriaxone, clindamycin, tetracycline and cephalotin and had a high sensitivity level to meropenem, vancomycin 
and oxacillin. Based on these results we concluded that the most common of urinary tract infections were caused 
by gram-negative bacteria species Escherichia coli. Encounters a high resistance pattern to 3rd generation 
cephalosporin antibiotics group, this was caused by the irrational use of antibiotics and the ability of bacteria to 
produce beta-lactamase enzymes which results in degradation of beta-lactam ring (β-lactam). We recommended 
the antibiotics group of chloramphenicol, gentamicin and vancomycin to use as empirical therapy in urinary tract 
infections. Antibiotic treatment should be prescribed only for as long as necessary to be effective. Recurrent 
urinary tract infections may be managed better by self initiated therapy or prophylaxis than by continuing to treat 
each case emergently. We also recommend health practitioners to use antibiotics rationally to prevent the 
resistances. 
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Introduction 
Urinary tract infection (UTI) is one of the most common medical problems. It was estimated 
that 150 million patients are diagnosed with a UTI yearly, resulting in at least $6 billion in 
health care expenditures. UTIs are difficult to diagnose; some cases respond to a short 
course of a specific antibiotic, while others require a longer course of a broad-spectrum 
antibiotic. Accurate diagnosis and treatment of a UTI is essential to limit associated 
morbidity and mortality and avoid prolonged or unnecessary use of antibiotics (Tanagho et 
al. 2008). Although susceptibility patterns have changed, the spectrum of agents that 
causing UTI has remained relatively constant. Escherichia coli accounts for 75% to 90% of 
cases; Staphylococcus saprophyticus accounts for 5% to 15% (particularly in younger 
women); and enterococci and non–E. coli aerobic gram negative rods, such as Klebsiella 
species and Proteus mirabilis, account for the remaining 5% to 10%. Although less well 
studied, the spectrum of agents causing uncomplicated pyelonephritis is similar to that 
causing acute cystitis (Gupta et al. 2001). 
The prevalence of uropathogens resistant to Trimethoprim/sulfamethoxazole (TMP-
SMZ), nitrofurantoin, and first-generation of cephalosporins are continuously rise. There are 
data that suggest overall resistance to TMP-SMZ is approximately 25% (range, 10-45%) 
based on the area of the country, and resistance to nitrofurantoin is slightly higher. Over 
the last decade, resistance to fluoroquinolones has been acceptably low in most studies; 
however, more recent microbiologic data showed that fluoroquinolone resistance, 
particularly in the West coast, may be an outbreaking problem (Killgore et al. 2004). 
The purpose of this study was to identify the patterns of antimicrobial resistance (as 
the primary outcome) and the most common bacterial that caused urinary tract infections 
(as the secondary outcome) in patients who’ve done examination of urine culture and 
sensitivity tests at laboratory of microbiology Dr. Zainoel Abidin Teaching Hospital, 
Indonesia. 
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Methods 
Study design and sampling strategy 
This research was descriptive study with retrospective approach by taking a cross-sectional 
data. Samples in this study were the result of urine culture examination that take from 
medical records  between  January until December 2010 on the laboratory of microbiology 
Dr. Zainoel Abidin Teaching Hospital Banda Aceh, Indonesia, which fulfill the inclusion 
criteria (data encountered bacterial pathogen cultured in urine samples and has a 
sensitivity test). The simple were the patients that have been hospitalized and diagnosed as 
UTI both in symptomatic or asymptomatic. 
A patient with UTI was defined as a patient who diagnosed with UTI (as stated on 
the laboratory referral documents) and already had an urine culture yielding ≥102 colonies 
per mL of urine with presumptively identified as bacteria pathogen.  
Urine specimen collection and microbiological methods 
All urine specimens data obtained from patients daily, preserved with glicerol 15%, and 
stored at -80°C until the testing. Urine specimens were cultured by standard methods of 
the American Society for Microbiology. All susceptibility testing was interpreted according to 
Clinical and Laboratory Standards Institute (Pezzlo et al. 2004). 
 
Results and Discussion 
We retrospectively viewed the medical records of 119 patients with UTIs between January 
to December 2010. Escherichia coli, Klepsiella pnemoniae, Acinetobacter were the most 
common pathogens gram-negative bacteria isolated from patients with community - 
acquired urinary tract infections that have been hospitalized, the isolated gram positive 
bacteria was; Beta-hemolytic streptococci and Staphylococcus aureus which is 9.2%, and 
3.4% (table 1). 
 This study provides current information regarding to etiologic agents that cause 
community-acquired UTI. The frequency distribution of the etiologic organisms within this 
study was quite consistent with the findings of previous study, who have been evaluated 
from three hundred patients that attending Dalhatu Araf Specialist Hospital, Lafia Nasarawa 
State, Nigeria. Results showed the most common organisms were Escherichia coli (Kolawole 
et al. 2009). This finding was also similar to other reports which indicated that gram 
negative bacteria, particularly E. coli, was the commonest pathogen isolated in patients 
with UTI (Burbige et al. 1984; Akinyemi et al. 1997; Ebie et al. 2001). 
Not all bacteria are capable to adhering and infecting the urinary tract. Any strains 
of Escherichia coli, belong to a limited number of O, K, and H serogroups. They had 
increased the adherence properties to uroepithelial cells and the resistance to the 
bactericidal activity of human serum, hemolysin, and the increased expression of K capsular 
antigen. The ability of E. coli to adhere the epithelial cells is mediated by ligands that 
located on the tips of the bacterial fimbriae (pili) (Tanagho et al. 2008). 
Recently, it has been observed that many bacteria such as E. coli have the ability to 
invade into the host cells, act as opportunistic intracellular pathogens (Bower et al, 2005). 
Cytotoxic necrotizing factor, Afa/Dr adhesions and type 1 pili have been shown to promote 
the invasion into the host cells. The intracellular bacteria mature into biofilms, creating pod-
like bulges on the urothelial surface (Anderson et al. 2003). The pods contain bacteria 
encased in a polysaccharide-rich matrix surrounded by a protective shell of uroplakin. The 
ability of the uropathogenic bacteria to transiently invade, survive, and multiply within the 
host cells and to create biofilms on genitourinary tract tissues may provide a mechanism for 
the persistence and recurrence of UTIs (Tanagho et al. 2008). 
Among the 37 E. coli isolates, the prevalence of resistance to ampicilin, 
ciprofloxacin, and cefotaxime was 91.9%, 83.7%, and 67.6%. No trends in the prevalence 
of resistance to meropenem, chloramphenicol, gentamicin, and tobramycin were detected. 
Ampicilin sensitivity  test against pathogenic bacteria that cause UTIs showed high 
levels of resistance against Enterobacter and Klepsiella pnemoniae, which is 100%. The 3rd 
generation cephalosporin class (cefotaxime) have also showed high levels of resistance to 
the bacteria E. coli, Acinetobacter, Pseudomonas aeruginosa and beta-hemolytic 
streptococci (these bacteria tested with the ceftriaxone) was 67.6%, 80%, 83.3%, and 
81.8% (Table 2). 
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Table 1. The Distribution of pathogenic bacteria that cause urinary tract infections, results 
of urinary tract isolates from January, 1 until December, 31, 2010 in the microbiology 
laboratorium Dr. Zainoel Abidin Teaching Hospital Banda Aceh, Indonesia 
No Type of bacteria  Percentage    
(%) 
 Gram-negative bacteria  
1 Escherichia coli 31.7 
2 Klepsiella pnemoniae 27.7 
3 Acinetobacter 12.6 
4 Pseudomonas aeruginosa 10.1 
5 Enterobacter 5.1 
6 Proteus mirabilis 0.8 
 Gram-positive bacteria  
1 
2 
Beta-hemolytic Streptococci 
Staphylococcus aureus 
9.2 
3.4 
 
Table 2. The patterns of antibiotic resistance in urinary tract infections that caused by 
Gram-negative bacteria  which are isolated in urinary tract through the antibiotic  
sensitivity test 
 
Bacteria  
 
Antibiotic 
 
Ampicilin  
 
(%) 
Cefota-
xime 
(%) 
Genta-
micine 
(%) 
Chloram-
phenicol 
(%) 
Merope-
nem 
(%) 
Ciproflo-
xacin 
(%) 
Cefuroxi-
me 
(%) 
Tobramycin  
 
(%) 
E. coli 
   Resistant 
   Sensitive  
 
91.9% 
8.1% 
 
67.6% 
32.4% 
 
19% 
81% 
 
32.4% 
67.6% 
 
0 
100% 
 
83.7% 
16.3% 
 
73% 
27% 
 
19% 
81% 
Kepsiella 
pneumoniae 
   Resistant 
   Sensitive 
 
 
100% 
0 
 
 
21.3% 
78.7% 
 
 
30.1 
69.9% 
 
 
12.1% 
87.9% 
 
 
0 
100% 
 
 
84.8% 
15.2% 
 
 
91% 
8% 
 
 
21.3% 
78.7% 
Acinetobacter 
   Resistant 
   Sensitive 
 
Not 
tested 
 
80% 
20% 
 
40% 
60% 
 
86.7% 
13.3% 
 
6.7% 
73.3% 
 
73.3% 
6.7% 
 
Not 
tested 
 
60% 
40% 
Enterobacter 
   Resistant 
   Sensitive  
 
100% 
0 
 
Not 
tested 
 
33.3% 
66.7% 
 
16.7% 
83.3% 
 
0 
100% 
 
50% 
50% 
 
83.3% 
16.7% 
 
Not tested 
Proteus 
mirabilis 
   Resistant 
   Sensitive 
 
Not 
tested 
 
 
100% 
0 
 
Not 
tested 
 
Not 
tested 
 
 
0 
100% 
 
Not 
tested 
 
 
100% 
0 
 
 
Not tested 
Pseudomonas 
aeruginosa 
   Resistant 
   Sensitive  
 
Not 
tested 
 
 
83.3% 
16.7% 
 
 
83.3% 
16.7% 
 
Not 
tested 
 
 
33.4 
66.6% 
 
 
50% 
50% 
 
Not 
tested 
 
 
Not tested 
 
Ampicilin, ciprofloxacin and cefotaxime has a high level resistance, these more likely 
caused by the irrational use of antibiotics. Irrational use of antibiotics is caused by the 
procurement and indiscriminate use.  
Antibiotic resistance in enterobacter, one of the most common pathogens in UTIs, 
has been encountered worldwide (Nys et al. 2008). The emergence of multidrug resistance 
(MDR) in E. coli, such as s extended-spectrum β-lactamase (ESBL)-producing strains. The 
overexpression of efﬂux pumps was reported to contribute to MDR of E. coli. Almost all 
Gram-negative bacteria have genes for efﬂux pumps to the resistance nodulation division 
(RND) family, and seven homologous RND-type pumps are known in E. coli. Five of these 
(AcrB, AcrF, MdtB, MdtC, and YhiV) are known to expel many kinds of drugs. The 
overexpression of this pump often associated with the MDR phenotype in E. coli. A previous 
report showed that a point mutation in yhiV, coding for YhiV, was associated with the 
differences in the MDR phenotype. The overexpression of efﬂux pump genes such as marA, 
yhiU, yhiV, and mdfA is related to antibiotic resistance, especially ﬂuoroquinolones 
(Yasufuku et al. 2010). 
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The characterization of efﬂux pumps could lead to the development of new weapons 
against antibiotic resistance, namely, efﬂux pump inhibitors (EPIs) (Page`s et al. 2009). 
EPIs efﬁciently inhibit the major AcrAB-TolC pump that responsible for MDR in E. coli 
(Page`s et al. 2009) and reduce the resistances to antibiotics in bacterial isolates (Yasufuku 
et al. 2010). 
One study investigated the correlation of antibiotic susceptibilities with the 
expression of the efﬂux pump genes in E. coli of UTI patients by quantitative real-time 
reverse transcription-PCR (qRT-PCR) and with risk factors for antibiotic resistance. The 
increasing expression of efﬂux pump genes such as marA and mdfA can lead to 
ﬂuoroquinolone resistance in E. coli. These results contribute to the efﬂux system and raise 
the possibility of developing new agents, such as EPIs, to antibiotic-resistant E. coli 
(Yasufuku et al. 2010). 
The low rate of ciprofloxacin (3.7%) resistance is noteworthy given its more than 13 
years of continued use in the United States. However, resistance was slightly higher (2.2%) 
than reported in previous North American surveillance studies (Gupta et al. 1999; Jones et 
al. 1999). Ciprofloxacin has maintained a high level of activity against UTI isolates of E. coli 
compared with other commonly used agents, such as ampicillin and trimethoprim 
sulfamethoxazole (SXT) (Gupta et al. 1999). The current data demonstrated that a 
ciprofloxacin-resistant phenotype without concurrent resistance to other classes of 
antimicrobials is rare (1.8%) (Sahm et al. 2001). Previous study performed by Canadian 
investigators described a correlation between resistance of ampicillin and resistance to SXT 
and ciprofloxacin in E. coli but did not describe MDR phenotypes or patient demographics 
(Zhanel et al 2000). Specifically, this study found the increasing rates of ampicillin 
resistance (91.9%) and ciprofloxacin- resistant (83.7%) for E. coli isolates. 
In this study we also compared the effectiveness of clindamycin against Beta-
hemolytic streptococci and Staphylococcus aureus. From the test result of this group  
antibiotic resistance rates were 90.9% and 75% (table 3). 
Among the 12 Beta-hemolytic streptococci isolates, the prevalence of resistance to 
meropenem and vancomycin was 0%, and 18.2%. No trends in the prevalence of resistance 
to meroponem, and vancomycin were detected. The pathogenic bacteria Staphylococcus 
aureus show the level of resistance to vancomycin and oxacillin is 0%. No profile resistance 
to vancomycin and oxacillin. 
The most useful antibiotics in this study were chloramphenicol, gentamicin, and 
vancomycin (in gram-positives) because they inhibit the most commonly isolated UTI 
pathogens. These drugs are relatively expensive compared to the most antibiotics 
frequently used. This probably restricted their procurement and indiscriminate use, making 
the organisms susceptible to it. This is different to other reports where quinolones are the 
most effective (susceptible) (Mbata. 2007). Ampicilin, ciprofloxacin and cefotaxime which 
are commonly used antibiotics were poorly effective against majority of the isolated 
organisms in this study. This is similar to other reports where ampicilin, ciprofloxacin and 
cefotaxime were poorly effective against majority of the organisms that caused UTI (Zhanel 
et al. 2000). The difference may be due to the practices of self medication and 
indiscriminate use of these antibiotics in this part of Nigeria and the acquiring of plasmid-
encoded resistance gene (Kolawole et al. 2009). 
The results of this study and those of others may be not representative for the 
general population. UTI are often treated empirically and susceptibility tests are often 
carried out only when the patient has failed once or in more courses of antibiotics. Even 
though the susceptibility pattern shown by this study buttressed the need for in-vitro 
sensitivity reports before antibiotics therapy initiation, however, it should be borne in mind 
that in-vitro antimicrobial sensitivity is only a guide and that conditions in-vivo may be 
quite different (Kolawole et al. 2009). 
Finally, the findings have no doubt in highlighted the need for constant monitoring of 
susceptibility of specific pathogens in different populations to commonly used anti-microbial 
agents. These data may be used to determine the trends in antimicrobial susceptibilities, 
formúlate the local antibiotic policies, compare to local and national data and to assist 
clinicians in the rational choice of antibiotic therapy to prevent misuse or overuse of 
antibiotics.  
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Table 3. The patterns of antibiotic resistance in UTIs that caused by Gram-positive bacteria  
which are isolated in urinary tract through the antibiotic sensitivity test 
 
Bacteria  
 
Antibiotic 
Ceftriaxone 
(%) 
Clindamycin 
(%) 
Tetracycline 
(%) 
Cephalotin 
(%) 
Meropenem 
(%) 
Vancomycin 
(%) 
Oxacillin 
(%) 
Beta-hemolytic 
Streptococci 
   Resistant 
   Sensitive  
 
 
81.8% 
18.2% 
 
 
90.9% 
9.1% 
 
 
81.8% 
18.2% 
 
 
Not tested 
 
 
Not tested 
 
 
18.2% 
81.8% 
 
 
Not 
tested  
Staphylococcus 
aureus 
   Resistant 
   Sensitive 
 
 
Not tested 
 
 
75% 
25% 
 
 
Not tested 
 
 
25% 
75% 
 
 
0 
100% 
 
 
100% 
0 
 
 
0 
100% 
        
 
Conclusions 
Based on these results, we concluded that UTIs more commonly caused by gram-negative 
bacteria species such us Escherichia coli. Encounters a high resistance pattern to 3rd 
generation cephalosporin antibiotics group, this is caused by the majority of irrational 
therapy for UTIs and urinary tract pathogens are demonstrating increasing antimicrobial 
resistance due to the ability to produce ESBL-producing strains. Antibiotics group 
chloramphenicol, gentamicin and vancomycin we recommend that for use as empirical 
therapy in urinary tract infection. Health practitioners to use antibiotic treatment should be 
prescribed only necessary to be effective. Continuously update the data on antimicrobial 
susceptibility patterns would be beneficial to guide empiric treatment. 
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